The expression of cocaine sensitization is not prevented by MK-801 or ibotenic acid lesions of the medial prefrontal cortex

Behavioural Brain Research

Volumn 104, Issue 1-2, 1999, Pages 119-125

  Li, Yong ^a   Wolf, Marina E ^a   White, Francis J ^a  

^a 3333 G   (United States)

Author keywords

Behavioral sensitization; Cocaine; Excitatory amino acids; MK 801; Prefrontal cortex; Ventral tegmental area

Indexed keywords

COCAINE; DIZOCILPINE; GLUTAMATE RECEPTOR ANTAGONIST; IBOTENIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BRAIN INJURY; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; LOCOMOTION; MALE; NERVE PROJECTION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SENSITIZATION; VENTRAL TEGMENTUM;

ANIMALS; BEHAVIOR, ANIMAL; COCAINE; COCAINE-RELATED DISORDERS; DIZOCILPINE MALEATE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EXCITATORY AMINO ACID ANTAGONISTS; IBOTENIC ACID; MALE; MICROINJECTIONS; MOTOR ACTIVITY; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0032874816     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(99)00060-1     Document Type: Article

References (45)

1. Banks K.E., Gratton A. Possible involvement of medial prefrontal cortex in amphetamine-induced sensitization of mesolimbic dopamine function. Eur. J. Pharmacol. 282:1995;157-167.
2. Cador M., Bjijou Y., Cailhol S., Stinus L. Role of a glutamatergic prefrontal/VTA innervation on amphetamine-induced behavioral sensitization to amphetamine. Soc. Neurosci. Abstr. 23:1997;1093.
3. Clark D., Overton P.G. Alterations in excitatory amino acid-mediated regulation of midbrain dopaminergic neurons induced by chronic psychostimulant administration and stress: relevance to behavioural sensitisation and drug addiction. Addict. Biol. 3:1998;109-135.
4. De Montis M.G., Devoto P., Meloni D., Gambarana C., Giorgi G., Tagliamonte A. NMDA receptor inhibition prevents tolerance to cocaine. Pharmacol. Biochem. Behav. 42:1992;179-182.
5. Haracz J.L., Belanger S.A., MacDonall J.S., Sircar R. Antagonists of N-methyl-D-aspartate receptors partially prevent the development of cocaine sensitization. Life Sci. 57:1995;2347-2357.
6. Horger B.A., Valadez A., Wellman P.J., Schenk S. Augmentation of the neurochemical effects of cocaine in the ventral striatum and medial prefrontal cortex following pre-exposure to amphetamine, but not nicotine: an in vivo microdialysis study. Life Sci. 55:1994;1245-1251.
7. Ida I., Asami T., Kuribara H. Inhibition of cocaine sensitization by MK-801, a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist: evaluation by ambulatory activity in mice. Jpn. J. Pharmacol. 69:1995;83-90.
8. Jeziorski M., White F.J., Wolf M.E. MK-801 prevents the development of behavioral sensitization during repeated morphine administration. Synapse. 16:1994;137-147.
9. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug and stress-induced sensitization of motor activity. Brain Res. Rev. 16:1991;223-224.
10. Kalivas P.W., Alesdatter J.E. Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. J. Pharmacol. Exp. Ther. 267:1993;486-495.
11. Karler R., Calder L.D., Chaudhry I.A., Turkanis S.A. Blockade of 'reverse tolerance' to cocaine and amphetamine by MK-801. Life Sci. 45:1989;599-606.
12. Karler R., Chaudhry I.A., Calder L.D., Turkanis S.A. Amphetamine behavioral sensitization and the excitatory amino acids. Brain Res. 537:1990;76-82.
13. Karler R., Calder L.D., Turkanis S.A. DNQX blockade of amphetamine behavioral sensitization. Brain Res. 552:1991;295-300.
14. Karler R., Calder L.D. Excitatory amino acids and the actions of cocaine. Brain Res. 582:1992;143-146.
15. Karler R., Calder L.D., Bedingfield J.B. Cocaine behavioral sensitization and the excitatory amino acids. Psychopharmacology. 115:1994;305-310.
16. Karler R., Calder L.D., Thai L.H., Bedingfield J.B. A dopaminergic-glutamatergic basis for the action of amphetamine and cocaine. Brain Res. 658:1994;8-14.
17. Karler R., Bedingfield J.B., Thai D.K., Calder L.D. The role of the frontal cortex in the mouse in behavioral sensitization to amphetamine. Brain Res. 757:1997;228-235.
18. Karreman M., Westerink B.H.C., Moghaddam B. Excitatory amino acid receptors in the ventral tegmental area regulate dopamine release in the ventral striatum. J. Neurochem. 67:1996;601-607.
19. Kauer J.A., Malenka R.C., Nicoll R.A. A persistent postsynaptic modification mediates long-term potentiation in the hippocampus. Neuron. 1:1988;911-917.
20. Kim H.-S., Park W.-K., Jang C.-G., Oh S. Inhibition by MK-801 of cocaine-induced sensitization, conditioned place preference, and dopamine-receptor supersensitivity in mice. Brain Res. Bull. 40:1996;201-207.
21. Kim J.-H., Vezina P. Metabotropic glutamate receptors are necessary for sensitization by amphetamine. NeuroReport. 9:1998;403-406.
22. Li Y., Vartanian A.J., White F.J., Xue C.-J., Wolf M.E. Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine. Psychopharmacology. 134:1997;266-276.
23. Li Y., Wolf M.E. Ibotenic acid lesions of prefrontal cortex do not prevent expression of behavioral sensitization to amphetamine. Behav. Brain Res. 84:1997;285-289.
24. Li Y., Wolf M.E. Can the 'state-dependency' hypothesis explain prevention of amphetamine sensitization in rats by NMDA receptor antagonists? Psychopharmacology. 141:1999;351-361.
25. Li, Y., Hu, X.-T., Berney, T.G., Stine, C., Vartanian, A.J., Wolf, M.E., White, F.J., 1999. Both glutamate receptor antagonists and prefrontal cortex lesions prevent the induction of cocaine sensitization and associated neuroadaptations. Synapse (in press).
26. Morrow B.A., Taylor J.R., Roth R.H. R-(+)-HA-966, an antagonist for the glycine/NMDA receptor, prevents locomotor sensitization to repeated cocaine exposures. Brain Res. 673:1995;165-169.
27. Muller D., Lynch G. Long-term potentiation differentially affects two components of synaptic responses in hippocampus. Proc. Natl. Acad. Sci. USA. 85:1988;9346-9350.
28. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1986;Academic, New York.
29. Pierce R.C., Bell K., Duffy P., Kalivas P.W. Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J. Neurosci. 16:1996;1550-1560.
30. Pierce R.C., Reeder D.C., Hicks J., Morgan Z.R., Kalivas P.W. Ibotenic acid lesions of the dorsal prefrontal cortex disrupt the expression of behavioral sensitization to cocaine. Neuroscience. 82:1998;1103-1114.
31. Pudiak C.M., Bozarth M.A. L-NAME and MK-801 attenuate sensitization to the locomotor-stimulating effect of cocaine. Life Sci. 53:1993;1517-1524.
32. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18:1993;247-291.
33. Schenk S., Snow S. Sensitization to cocaine's motor activating properties produced by electrical kindling of the medial prefrontal cortex but not of the hippocampus. Brain Res. 659:1994;17-22.
34. Sesack S.R., Deutch A.Y., Roth R.H., Bunney B.S. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris Leucoagglutinin. J. Comp. Neurol. 290:1989;213-242.
35. Sesack S.R., Pickel V.M. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J. Comp. Neurol. 320:1992;145-160.
36. Shoaib M., Shippenberg T.S., Goldberg S.R., Schindler C.W. Behavioral studies with the glycine partial agonist (+)-HA966 on cocaine-induced locomotor activity and reinforcement. Behav. Pharmacol. 6:1995;568-576.
37. Sorg B.A., Davidson D.L., Kalivas P.W., Prasad B.M. Repeated daily cocaine alters subsequent cocaine-induced increase of extracellular dopamine in the medial prefrontal cortex. J. Pharmacol. Exp. Ther. 281:1997;54-61.
38. Taber M.T., Das S., Fibiger H.C. Cortical regulation of subcortical dopamine release: mediation via the ventral tegmental area. J. Neurochem. 65:1995;1407-1410.
39. Tong Z.-Y., Overton P.G., Clark D. Chronic administration of (+)-amphetamine alters the reactivity of midbrain dopaminergic neurons to prefrontal cortex stimulation in the rat. Brain Res. 674:1995;63-74.
40. Tzschentke T.M., Schmidt W.J. The development of cocaine-induced behavioral sensitization is affected by discrete quinolinic acid lesions of the prelimbic medial prefrontal cortex. Brain Res. 795:1998;71-76.
41. Wolf M.E., Khansa M. Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine. Brain Res. 562:1991;164-168.
42. Wolf M.E., Jeziorski M. Co-administration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization. Brain Res. 613:1993;291-294.
43. Wolf M.E., White F.J., Hu X.-T. Behavioral sensitization to MK-801 (dizocilpine): neurochemical and electrophysiological correlates in the mesoaccumbens dopamine system. Behav. Pharmacol. 4:1993;429-442.
44. Wolf M.E., Dahlin S.L., Hu X.-T., Xue C.-J., White K. Effects of lesions of prefrontal cortex, amygdala, or fornix on behavioral sensitization to amphetamine: comparison with N-methyl-D-aspartate antagonists. Neuroscience. 69:1995;417-439.
45. Wolf M.E. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog. Neurobiol. 54:1998;679-720.